Mindbloom, Inc. operates in the mental health sector, providing clinician-guided ketamine therapy for individuals suffering from anxiety and depression. The company serves clients with moderate to severe symptoms, offering a customized program tailored to each individual's unique mental health challenges. Mindbloom's business model involves partnering with independently owned and operated psychiatric medical practices, ensuring that all treatments are prescribed and supervised by medically licensed clinicians. The company generates revenue through service fees for therapy sessions, which are conducted both in-person and via telehealth platforms. Mindbloom emphasizes safety and efficacy, boasting over 300,000 completed sessions and a high success rate in symptom relief. The company aims to increase access to science-backed mental health treatments, transforming lives through innovative therapeutic approaches.

Keywords: ketamine therapy, mental health, anxiety, depression, clinician-guided, customized programs, safety protocols, psychiatric practices, telehealth, symptom relief.